NeuroPace, Inc. (NPCE) vs Sight Sciences, Inc. (SGHT)
A side-by-side comparison of NeuroPace, Inc. and Sight Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NPCE
NeuroPace, Inc.
$13.06HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
SGHT
Sight Sciences, Inc.
$8.60HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — NPCE vs SGHT
growth of $100 · dividends reinvested · last 5yNPCE -46.0% (-11.6%/yr)SGHT -73.4% (-23.3%/yr)NPCE compounded faster over this window
NPCE SGHT
NPCE vs SGHT: by the numbers
- •SGHT is the larger company ($468M vs $445M market cap).
- •Both run net losses; NPCE's is the smaller (-19.34% vs -35.69% net margin).
- •SGHT grew revenue faster over the past five years (16.53% vs 15.85% CAGR).
Metrics side by side
Valuation
| Metric | NPCE | SGHT |
|---|---|---|
| P/S ratio | 4.50 | 5.61 |
| P/B ratio | 37.46 | 8.84 |
Profitability
| Metric | NPCE | SGHT |
|---|---|---|
| Gross margin | 79.63% | 87.96% |
| Operating margin | -15.26% | -47.95% |
| Net margin | -19.34% | -35.69% |
| ROE | -160.85% | -56.26% |
| ROIC | -18.95% | -29.50% |
Growth (annualized)
| Metric | NPCE | SGHT |
|---|---|---|
| Revenue CAGR (5Y) | 15.85% | 16.53% |
| Total return CAGR (5Y) | -4.94% | -18.69% |
Frequently asked
- Which has grown faster, NPCE or SGHT?
- Over the past five years, SGHT grew revenue faster — NPCE at a 15.85% CAGR versus SGHT at 16.53%.
- How have NPCE and SGHT total returns compared?
- Over the past 5 years, NPCE delivered -4.94% and SGHT delivered -18.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
NeuroPace ROESight Sciences ROENeuroPace operating marginSight Sciences operating marginNeuroPace revenue growthSight Sciences revenue growthNeuroPace free cash flowSight Sciences free cash flow
NeuroPace & Sight Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.